company background image
PBH logo

Prestige Consumer Healthcare NYSE:PBH Stok Raporu

Son Fiyat

US$74.77

Piyasa Değeri

US$3.7b

7D

1.7%

1Y

24.9%

Güncellenmiş

05 Nov, 2024

Veri

Şirket Finansalları +

Prestige Consumer Healthcare Inc.

NYSE:PBH Stok Raporu

Piyasa değeri: US$3.7b

PBH Stoklara Genel Bakış

Prestige Consumer Healthcare Inc. iştirakleriyle birlikte Kuzey Amerika, Avustralya ve uluslararası alanda reçetesiz (OTC) sağlık ve kişisel bakım ürünleri geliştirmekte, üretmekte, pazarlamakta, dağıtmakta ve satmaktadır.

Şirket hakkında

Ödüller

Adil değer tahminimizden 52.1% daha düşük bir oranda işlem görüyor
Kazançların yılda 4.98% oranında artması öngörülüyor
Bu yıl karlı hale geldi
Rakiplerine ve sektöre kıyasla iyi değerde işlem görüyor

Risk Analizi

Yüksek borç seviyesine sahip

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WA
WarrenAI
Based on Analyst Price Targets

Brand Building And Innovations Propel Long-Term Growth Amid Supply Chain Challenges

Key Takeaways Investments in brand building and marketing for key products like Hydralyte and Summer's Eve are enhancing consumer awareness and driving revenue growth. Effective supply chain management and strategic product innovations are positioning Prestige Consumer Healthcare for increased market share and international expansion.
View narrative
US$79.43
FV
5.9% undervalued intrinsic discount
2.43%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
7 days ago author updated this narrative

Prestige Consumer Healthcare Inc. Rakipler

Organon

NYSE:OGN

US$4.4b

Corcept Therapeutics

NasdaqCM:CORT

US$5.2b

Amphastar Pharmaceuticals

NasdaqGS:AMPH

US$2.5b

Jazz Pharmaceuticals

NasdaqGS:JAZZ

US$6.8b

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Prestige Consumer Healthcare
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıUS$74.77
52 Haftanın En Yüksek SeviyesiUS$75.80
52 Haftanın En Düşük SeviyesiUS$56.61
Beta0.47
11 Aylık Değişim8.63%
3 Aylık Değişim10.13%
1 Yıllık Değişim24.87%
33 Yıllık Değişim19.48%
5 Yıllık Değişim98.07%
Halka arzdan bu yana değişim321.24%

Son Haberler & Güncellemeler

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Nov 03
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Sep 10
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Recent updates

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Nov 03
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Sep 10
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Jul 16
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

May 22
Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 26
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Mar 05
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Feb 11
Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Feb 05
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Dec 14
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Sep 10
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Prestige Consumer Healthcare: Unproductive Buyback And Excessive Valuation

Aug 15

Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

Jun 12
Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

May 20
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Mar 17
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 02
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Feb 08
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Prestige Consumer Healthcare reports Q3 earnings beat; updates FY23 guidance

Feb 02

Prestige Consumer Healthcare: Taking My Winnings Off The Table

Jan 19

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Nov 23
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare GAAP EPS of $1.02 beats by $0.02, revenue of $289.3M beats by $6.07M

Nov 03

Holding Prestige Consumer Healthcare

Aug 31

If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

Aug 26
If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Aug 05
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare GAAP EPS of $1.09 beats by $0.05, revenue of $277.1M beats by $8.18M

Aug 04

Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

May 27
Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

May 05
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Feb 22
Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Feb 03
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Nov 04
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden

Aug 06
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden

Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 50% Below Their Intrinsic Value Estimate

Jun 14
Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 50% Below Their Intrinsic Value Estimate

Hissedar Getirileri

PBHUS PharmaceuticalsUS Pazar
7D1.7%-4.8%-0.8%
1Y24.9%14.1%31.5%

Getiri vs. Endüstri: PBH geçen yıl % 14.1 oranında getiri sağlayan US Pharmaceuticals sektörünü aştı.

Getiri vs Piyasa: PBH geçen yıl % 31.5 oranında getiri sağlayan US Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is PBH's price volatile compared to industry and market?
PBH volatility
PBH Average Weekly Movement2.6%
Pharmaceuticals Industry Average Movement9.4%
Market Average Movement6.0%
10% most volatile stocks in US Market15.1%
10% least volatile stocks in US Market2.8%

İstikrarlı Hisse Senedi Fiyatı: PBH son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: PBH 'nin haftalık oynaklığı ( 3% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
1996570Ron Lombardiwww.prestigebrands.com

Prestige Consumer Healthcare Inc. iştirakleriyle birlikte Kuzey Amerika, Avustralya ve uluslararası alanda reçetesiz (OTC) sağlık ve kişisel bakım ürünleri geliştirmekte, üretmekte, pazarlamakta, dağıtmakta ve satmaktadır. Şirket, Kuzey Amerika OTC Healthcare ve Uluslararası OTC Healthcare olmak üzere iki segmentte faaliyet göstermektedir. BC ve Goody's markaları altında analjezik tozlar; Boudreaux's Butt Paste markası altında bebekler için pişik tedavileri ve cilt koruyucular; Chloraseptic markası altında boğaz ve ağız ağrısını hafifletmek için spreyler ve pastiller; Clear Eyes markası altında kızarıklık ve kaşıntıdan kurtulmayı sağlayan göz bakım ürünleri; Compound W markası altında yaygın ve plantar siğillerin evde giderilmesi; ve kulak kirini gidermek için Debrox sunmaktadır.

Prestige Consumer Healthcare Inc. Temel Bilgiler Özeti

Prestige Consumer Healthcare'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
PBH temel i̇stati̇sti̇kler
Piyasa değeriUS$3.66b
Kazançlar(TTM)US$205.13m
Gelir(TTM)US$1.11b

18.1x

F/K Oranı

3.3x

P/S Oranı

PBH aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
PBH gelir tablosu (TTM)
GelirUS$1.11b
Gelir MaliyetiUS$488.83m
Brüt KârUS$624.36m
Diğer GiderlerUS$419.23m
KazançlarUS$205.13m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

Nov 07, 2024

Hisse başına kazanç (EPS)4.14
Brüt Marj56.09%
Net Kâr Marjı18.43%
Borç/Özkaynak Oranı64.9%

PBH uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün